Durable remission of metastatic renal cell carcinoma with gemcitabine and capecitabine after failure of targeted therapy

J Clin Oncol. 2011 Mar 10;29(8):e203-5. doi: 10.1200/JCO.2010.31.6091. Epub 2010 Dec 20.

Authors

Stephen L Richey¹, Chaan Ng, Zita D Lim, Eric Jonasch, Nizar M Tannir

Affiliation

¹ The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Capecitabine
Carcinoma, Renal Cell / drug therapy*
Carcinoma, Renal Cell / enzymology
Carcinoma, Renal Cell / secondary
Deoxycytidine / administration & dosage
Deoxycytidine / analogs & derivatives
Fluorouracil / administration & dosage
Fluorouracil / analogs & derivatives
Gemcitabine
Humans
Kidney Neoplasms / drug therapy*
Kidney Neoplasms / enzymology
Kidney Neoplasms / pathology
Male
Middle Aged
Molecular Targeted Therapy
Protein Kinase Inhibitors / therapeutic use*
Remission Induction
Time Factors
Tomography, X-Ray Computed
Treatment Failure

Substances

Protein Kinase Inhibitors
Deoxycytidine
Capecitabine
Fluorouracil
Gemcitabine